CNS Melanoma

CNS melanoma refers to melanoma that develops in the central nervous system. Melanoma is a type of cancer that arises from pigment-producing cells in the skin. It typically starts with a mole, but can quickly spread to other organs, including the brain. Once it spreads to the brain or spinal cord, it is called CNS melanoma. CNS melanoma is a rare form of melanoma, but it can be devastating. It can cause headaches, seizures, and other neurological symptoms. Treatment for CNS melanoma is challenging, and it often involves a combination of surgery, radiation therapy, and chemotherapy. However, the prognosis for individuals with CNS melanoma is generally poor, with a five-year survival rate of less than 10%. Hematology and oncology research have made significant progress in understanding the causes of melanoma and developing advanced treatments. Scientists continue to investigate the genetic and environmental factors that increase the risk of developing melanoma. They are also exploring new therapies that target specific genetic mutations in the cancer cells. 

← Hematology Research and Oncology Research

Related Articles

7 article(s) found
Primary Malignant Melanoma Of The Parotid Gland Combined 18F-FDGPET/CT And Immunochemical Diagnosis with Literature Review
Full-text HTML Download PDF Download XML
Combination of Radiation Therapy and Immunotherapy in the Treatment of Melanoma
Full-text HTML Download PDF Download XML
Blockade of Programmed Cell Death Protein-1 Pathway for the Treatment of Melanoma
Full-text HTML Download PDF Download XML
Melanoma of the Breast with Smoothened (SMO) Mutation: Case Report and review of the Literature
Full-text HTML Download PDF Download XML
Pharmacodynamic Modeling of Sunscreens: New Efficacy Evaluation, Risks of Sunburn and Melanoma and Very Low to Very High Sun Protection Factor
Full-text HTML Download PDF Download XML
Metastatic Malignant Melanoma of the Gastrointestinal Tract: A Rare Case and Review of Current Literature
Full-text HTML Download PDF Download XML
Dynamic MicroRNA-Expression in Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival
Full-text HTML Download PDF Download XML